Cargando…
Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures
Peritoneal dialysis (PD) is a modality of renal replacement therapy in which the high volumes of available PD effluent (PDE) represents a rich source of biomarkers for monitoring disease and therapy. Although this information could help guide the management of PD patients, little is known about the...
Autores principales: | Herzog, Rebecca, Boehm, Michael, Unterwurzacher, Markus, Wagner, Anja, Parapatics, Katja, Májek, Peter, Mueller, André C., Lichtenauer, Anton, Bennett, Keiryn L., Alper, Seth L., Vychytil, Andreas, Aufricht, Christoph, Kratochwill, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836375/ https://www.ncbi.nlm.nih.gov/pubmed/29208752 http://dx.doi.org/10.1074/mcp.RA117.000186 |
Ejemplares similares
-
Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
por: Wiesenhofer, Florian M., et al.
Publicado: (2019) -
Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses – A First-In-Man Trial
por: Kratochwill, Klaus, et al.
Publicado: (2016) -
Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
por: Herzog, Rebecca, et al.
Publicado: (2017) -
Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses
por: Herzog, Rebecca, et al.
Publicado: (2020) -
The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation
por: Boehm, Michael, et al.
Publicado: (2019)